Robotic resection of extrahepatic cholangiocarcinoma: Institutional outcomes of bile duct cancer surgery using a minimally invasive technique.


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Feb 2022
Historique:
revised: 09 08 2021
received: 12 07 2021
accepted: 28 08 2021
pubmed: 16 9 2021
medline: 18 1 2022
entrez: 15 9 2021
Statut: ppublish

Résumé

The purpose of this study is to report our early experience and outcomes, the first in North America, of Extrahepatic Cholangiocarcinoma (EHC) resection with Roux-en Y Hepaticojejunostomy reconstruction via the robotic approach. With Institutional Review Board approval, 15 patients who underwent robotic resection of EHC were studied. Patients were 74 (73 ± 8.9) years of age. There were 9 men and 6 women. Average body mass index was 24 (27 ± 6.3) kg·m Robotic resection of EHC is safe, feasible, and reproducible with excellent clinical outcomes. Consequently, the robotic technique should be considered in some patients requiring EHC resection.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
The purpose of this study is to report our early experience and outcomes, the first in North America, of Extrahepatic Cholangiocarcinoma (EHC) resection with Roux-en Y Hepaticojejunostomy reconstruction via the robotic approach.
METHODS METHODS
With Institutional Review Board approval, 15 patients who underwent robotic resection of EHC were studied.
RESULTS RESULTS
Patients were 74 (73 ± 8.9) years of age. There were 9 men and 6 women. Average body mass index was 24 (27 ± 6.3) kg·m
DISCUSSION CONCLUSIONS
Robotic resection of EHC is safe, feasible, and reproducible with excellent clinical outcomes. Consequently, the robotic technique should be considered in some patients requiring EHC resection.

Identifiants

pubmed: 34524689
doi: 10.1002/jso.26674
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

161-167

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Poruk, KE, Pawlik TM, Weiss MJ. Perioperative management of hilar cholangiocarcinoma. J Gastrointest Surg. 2015;19:1889-1899.
Singhal D, Van Gulik TM, Gouma DJ. Palliative management of hilar cholangiocarcinoma. Surg Oncol. 2005;14:59-74.
Blechacz B. Cholangiocarcinoma: current knowledge and new developments. Gut Liver. 2017;11:13-26.
Sucandy I, Luberice K, Rivera-Espineira G, et al. Robotic major hepatectomy: influence of age on clinical outcomes. Am Surg. 2021;87:114-119.
Sucandy I, Luberice K, Lippert T, et al. Robotic major hepatectomy: an institutional experience and clinical outcomes. Ann Surg Oncol. 2020;27:4970-4979.
Sucandy I, Giovannetti A, Spence J, Ross S, Rosemurgy A. Robotic partial right hepatectomy for intrahepatic cholangiocarcinoma: how we do it. Am Surg. 2020;86:389-390.
Sucandy I, Wecowski J, Schlosser S, et al. Institutional experience of robotic liver resection: outcome comparison with NSQIP data. Am Surg. 2020;86:e156-e158.
Xu Y, Wang H, Ji W, et al. Robotic radical resection for hilar cholangiocarcinoma: perioperative and long-term outcomes of an initial series. Surg Endosc. 2016;30:3060-3070.
Swaid F, Sucandy I, Tohme S, et al. Changes in performance of more than 1000 minimally invasive liver resections. JAMA Surg. 2020;155:986-988.
Ciria R, Berardi G, Alconchel F, et al. The impact of robotics in liver surgery: a worldwide systematic review and short-term outcomes meta-analysis on 2,728 cases. J Hepatobiliary Pancreat Sci. Published online November 17, 2020. https://doi.org/10.1002/jhbp.869
Wang W, Fei Y, Liu J, Yu T, Tang J, Wei F. Laparoscopic surgery and robotic surgery for hilar cholangiocarcinoma: an updated systematic review. ANZ J Surg. 2021;91:42-48.
Chou S, Chang ZY, Zhao GD, et al. [Robotic hilar cholangiocarcinoma radical resection compared with laparotomy in prognosis]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 2020;58:230-234.
Li J, Tan X, Zhang X, et al. Robotic radical surgery for hilar cholangiocarcinoma: a single-centre case series. Int J Med Robot. 2020;16:e2076.

Auteurs

Iswanto Sucandy (I)

Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA.

Emanuel Shapera (E)

Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA.

Kevin Jacob (K)

Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA.

Kenneth Luberice (K)

Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA.

Kaitlyn Crespo (K)

Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA.

Cameron Syblis (C)

Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA.

Sharona B Ross (SB)

Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA.

Alexander S Rosemurgy (AS)

Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH